151 related articles for article (PubMed ID: 10629660)
21. Comparing modeling strategies combining changes in multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancer.
van Delft FA; Schuurbiers MMF; Muller M; Burgers SA; van Rossum HH; IJzerman MJ; van den Heuvel MM; Koffijberg H
Tumour Biol; 2024; 46(s1):S269-S281. PubMed ID: 37545289
[TBL] [Abstract][Full Text] [Related]
22. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.
Grunnet M; Sorensen JB
Lung Cancer; 2012 May; 76(2):138-43. PubMed ID: 22153832
[TBL] [Abstract][Full Text] [Related]
23. [Tumor markers in lung cancer].
Niho S; Shinkai T
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2089-93. PubMed ID: 11791391
[TBL] [Abstract][Full Text] [Related]
24. Clinical tumour markers in lung cancer.
Niklinski J; Furman M
Eur J Cancer Prev; 1995 Apr; 4(2):129-38. PubMed ID: 7539317
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
26. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?
Ebert W; Muley T; Drings P
Anticancer Res; 1996; 16(4B):2161-8. PubMed ID: 8694537
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of CYFRA 21 - 1 and Ki67 in advanced NSCLC patients with wild-type EGFR.
Li T; Xie Q; Fang YY; Sun Y; Wang XM; Luo Z; Yan GL; He JB; Zheng XQ
BMC Cancer; 2023 Mar; 23(1):295. PubMed ID: 37004004
[TBL] [Abstract][Full Text] [Related]
28. Identification of pyroptosis-related long non-coding RNAs with prognosis and therapy in lung squamous cell carcinoma.
Zhang Y; Wang Y; Yin X; Huang Y
Sci Rep; 2022 Jul; 12(1):11206. PubMed ID: 35778526
[TBL] [Abstract][Full Text] [Related]
29. Risk factor of brain metastases and its influence on patient prognosis after complete resection of non-small cell lung cancer.
Li J
Am J Transl Res; 2022; 14(1):406-413. PubMed ID: 35173859
[TBL] [Abstract][Full Text] [Related]
30. Abnormal sialylation and fucosylation of saliva glycoproteins: Characteristics of lung cancer-specific biomarkers.
Gao Z; Xu M; Yue S; Shan H; Xia J; Jiang J; Yang S
Curr Res Pharmacol Drug Discov; 2022; 3():100079. PubMed ID: 35005612
[TBL] [Abstract][Full Text] [Related]
31. Clinical Associations of Preoperative and Postoperative Serum CEA and Lung Cancer Outcome.
Jiao Z; Cao S; Li J; Hu N; Gong Y; Wang L; Jin S
Front Mol Biosci; 2021; 8():686313. PubMed ID: 34778369
[No Abstract] [Full Text] [Related]
32. The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types.
Chen H; Fu F; Zhao Y; Wu H; Hu H; Sun Y; Zhang Y; Xiang J; Zhang Y
Front Oncol; 2021; 11():645159. PubMed ID: 34178632
[TBL] [Abstract][Full Text] [Related]
33. [Semiquantitative parameters of
Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893
[TBL] [Abstract][Full Text] [Related]
34. Correlation between combining
Ruan M; Liu L; Wang L; Lei B; Sun X; Chang C; Shen Y; Xie W
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1183-1197. PubMed ID: 31897590
[TBL] [Abstract][Full Text] [Related]
35. Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer.
Yoshimura A; Uchino J; Hasegawa K; Tsuji T; Shiotsu S; Yuba T; Takumi C; Yamada T; Takayama K; Hiraoka N
Transl Lung Cancer Res; 2019 Jun; 8(3):227-234. PubMed ID: 31367536
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the clinical application of multiple tumor marker protein chip in the diagnostic of lung cancer.
Wang X; Zhang Y; Sun L; Wang S; Nie J; Zhao W; Zheng G
J Clin Lab Anal; 2018 Oct; 32(8):e22565. PubMed ID: 29736949
[TBL] [Abstract][Full Text] [Related]
37. Pragmatic RAndomised controlled trial of a trauma-focused guided self-help Programme versus InDividual trauma-focused cognitive Behavioural therapy for post-traumatic stress disorder (RAPID): trial protocol.
Nollett C; Lewis C; Kitchiner N; Roberts N; Addison K; Brookes-Howell L; Cosgrove S; Cullen K; Ehlers A; Heke S; Kelson M; Lovell K; Madden K; McEwan K; McNamara R; Phillips C; Pickles T; Simon N; Bisson J
BMC Psychiatry; 2018 Mar; 18(1):77. PubMed ID: 29580220
[TBL] [Abstract][Full Text] [Related]
38. Current and Prospective Protein Biomarkers of Lung Cancer.
Zamay TN; Zamay GS; Kolovskaya OS; Zukov RA; Petrova MM; Gargaun A; Berezovski MV; Kichkailo AS
Cancers (Basel); 2017 Nov; 9(11):. PubMed ID: 29137182
[TBL] [Abstract][Full Text] [Related]
39. Screening and Biosensor-Based Approaches for Lung Cancer Detection.
Wang L
Sensors (Basel); 2017 Oct; 17(10):. PubMed ID: 29065541
[TBL] [Abstract][Full Text] [Related]
40. Top-down nanofabrication of silicon nanoribbon field effect transistor (Si-NR FET) for carcinoembryonic antigen detection.
Bao Z; Sun J; Zhao X; Li Z; Cui S; Meng Q; Zhang Y; Wang T; Jiang Y
Int J Nanomedicine; 2017; 12():4623-4631. PubMed ID: 28721039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
